Watson Pharmaceuticals, Inc. v. Schwetz
This text of 38 F. App'x 578 (Watson Pharmaceuticals, Inc. v. Schwetz) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
ON MOTION
ORDER
Bristol-Myers Squibb Co., Watson Pharmaceuticals, Inc. and Danbury Phar-macal, Inc. move jointly to voluntarily dismiss with prejudice. The Acting Principal Deputy Commissioner consents.
Upon consideration thereof,
IT IS ORDERED THAT:
(1) The unopposed motion to dismiss is granted.
(2) The motion to transfer is moot.
(3) All sides shall bear their own costs.
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
38 F. App'x 578, Counsel Stack Legal Research, https://law.counselstack.com/opinion/watson-pharmaceuticals-inc-v-schwetz-cafc-2002.